Family CFO Inc Sells 1,395 Shares of SPDR S&P Biotech ETF $XBI

Family CFO Inc trimmed its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 72.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 526 shares of the exchange traded fund’s stock after selling 1,395 shares during the quarter. Family CFO Inc’s holdings in SPDR S&P Biotech ETF were worth $44,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in XBI. Provident Wealth Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 3,000.0% in the first quarter. Provident Wealth Management LLC now owns 310 shares of the exchange traded fund’s stock worth $25,000 after purchasing an additional 300 shares during the last quarter. Garrison Bradford & Associates Inc. bought a new stake in shares of SPDR S&P Biotech ETF in the first quarter worth about $39,000. Compass Wealth Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 46.0% in the first quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock worth $51,000 after purchasing an additional 200 shares during the last quarter. Golden State Wealth Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 100.0% in the first quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock worth $52,000 after purchasing an additional 319 shares during the last quarter. Finally, Avalon Trust Co bought a new stake in shares of SPDR S&P Biotech ETF in the first quarter worth about $57,000.

SPDR S&P Biotech ETF Trading Up 1.2%

Shares of XBI stock opened at $102.59 on Friday. SPDR S&P Biotech ETF has a 12-month low of $66.66 and a 12-month high of $105.47. The stock’s 50-day moving average price is $91.78 and its 200-day moving average price is $85.05. The stock has a market capitalization of $5.85 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.